⌘K

Home/Filings/4/0000914190-17-000273

4//SEC Filing

Bove Mauro 4

Accession 0000914190-17-000273

CIK 0000707511other

View on SEC.gov Company Profile

Filed

Sep 5, 8:00 PM ET

Accepted

Sep 6, 4:17 PM ET

Size

5.4 KB

Accession

0000914190-17-000273

Insider Transaction Report

Form 4

Period: 2017-09-01

REGENERX BIOPHARMACEUTICALS INCRGRX

Director

Transactions

Award
Stock Option (right to buy)
2017-09-01+125,000→ 125,000 total
Exercise: $0.28Exp: 2027-09-01→ Common Stock (125,000 underlying)

Footnotes (1)

[F1]The option vests in four equal annual installments beginning on September 1, 2017.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

REGENERX BIOPHARMACEUTICALS INC

CIK 0000707511

Entity typeother

Related Parties

1

filerCIK 0001396271

Filing Metadata

Form type: 4
Filed: Sep 5, 8:00 PM ET
Accepted: Sep 6, 4:17 PM ET
Size: 5.4 KB

View on SEC.gov